 |
|
|
|
|
| Agence de la biomedicine News |
|
back |
|
|
 The French Biomedicine Agency is a public organisation under the supervision of the Minister of Health, operating in four key areas of human biology and medicine: assisted reproductive technologies,
prenatal and genetic diagnosis, embryo and stem cell research, and the procurement and transplant of
organs, tissues and cells, previously entrusted to L'Etablissement franηais des Greffes (the French
Transplant Agency) between 1994 and 2005.
These medical activities present major therapeutic, health and ethical issues. Interacting with society at large, the agency's mission is to provide professionals and researchers with collective answers to the questions they encounter. Its underlying goal is to improve care for patients.
The French Biomedicine Agency was created by virtue of the Bioethics Law of August 6, 2004.
It guarantees equity, ethics and transparency for the activities under its responsibility, and for anticipated developments.
Eight priorities for 2005-2008
Continue improving access to organ, tissue and cell transplants
Improve care for assisted reproductive technologies, prenatal diagnosis and the examination of genetic characteristics
Develop and ensure the quality, safety and evaluation of medical activities and practices
Deliver authorizations and approvals, and monitor them
Contribute to ethical debate, and to the dissemination and respect of ethical principles in activities within the agency's scope
Promote research in the agency's areas of activity and foster respect for ethical principles in embryo research
Develop information for authorities, health professionals and French citizens
Contribute effectively to regulatory and international activities as well as public health policies
The French Biomedicine Agency: organisation
The French Biomedicine Agency has its head office in Saint-Denis near Paris, where two main policies are defined:
the agency's medical policy and monitoring of its application, in relation with a number of expert groups,
information and communication policy towards professionals and the general public.
The head office also houses:
the computer systems required to carry out agency missions and evaluate care activities,
the management of existing or future national registers: patients awaiting organ and cornea transplants, those who refuse to be donors of organs and tissues, volunteer donors of haematopoietic stem cells, children born of in vitro fertilization, oocyte donors, etc.,
a training and information centre.
In the provinces, regulation and support departments represent the agency and ensure 24/7 missions for procurement and transplantation.
The French Biomedicine Agency is equipped with:
an executive board of representatives from different ministries and public health bodies, together with key figures qualified in the agency's fields of activity,
a steering committee which supervises the consistency of the Agency's medical and scientific policy, and compliance with the regulatory and ethical principles applicable to its activities. It comprises scientific and medical experts, representatives from associations, qualified key figures, members of different institutions (e.g., the French Consultative Committee for Ethics, and the French Consultative Commission for Human Rights), as well as Members of Parliament.
The agency draws on a medical and scientific committee and on groups of experts for its medical and scientific expertise.
Working closely with these different experts, the French Biomedicine Agency organises
discussions with doctors, scientists, authorities and the general public.
Download full presentation (PDF, 189 KB)
|
 |
21.06.2007 - |
| |
Please, download the PDF file |
| |
13.06.2006 - |
| |
Please, download the PDF file (32KB). |
| |
07.04.2006 - |
| |
Please, download the PDF file (77KB). - Download PDF
|
| |
08.02.2006 - |
| |
Please, download the PDF file (40KB). - Download PDF |
|
|
| |
